Skip to main content
Home

Top menu InfoLep

  • About InfoLep


Main navigation

  • Home
  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day 2023
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Antimicrobial resistance in leprosy
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Publications
  • Practical materials
  • Organizations

Top menu - mobile infoLep

  • About InfoLep

Refine your results

Refine your results


Selected filters

  • Reset filters
  • 2021
  • 2015
  • Mycobacterium indicus pranii (MIP)

Filter by type

  • Publications

NTD

  • Leprosy (Hansen disease) (1)

Subject

  • (-) Mycobacterium indicus pranii (MIP) (11)
  • Immunoprophylaxis / Vaccine (5)
  • Tuberculosis (1)
  • Erythema nodosum leprosum - enl (Type 2 reaction) (1)
  • Complications and reactions (1)

Resource type

  • Article (11)
  • Full text online (6)

Target audience

Journal

  • American journal of reproductive immunology (New York, N.Y. : 1989) (1)
  • Annals of clinical microbiology and antimicrobials (1)
  • BMC infectious diseases (1)
  • Cancer biology & therapy (1)
  • Journal of critical care (1)
  • Journal of leukocyte biology (2)
  • Journal of the European Academy of Dermatology and Venereology : JEADV (1)
  • mBio (2)
  • Oncoimmunology (1)

Year of Publication

  • (-) 2021 (1)
  • 2019 (4)
  • 2018 (2)
  • 2017 (6)
  • 2016 (10)
  • (-) 2015 (10)
  • 2014 (7)
  • 2013 (3)
  • 2012 (9)
  • 2011 (4)
  • 2009 (1)
  • 2007 (1)

Language

  • English (11)
 
  • Relevance
  • Date
11 items

Publication

Recurrent Erythema Nodosum Leprosum Associated With Mycobacterium Indicus Pranii Vaccine In A Case Of Leprosy: A Rare paradox.

Kothari R, Vashisht D, Pudasaini N, et al. Journal of the European Academy of Dermatology and Venereology : JEADV. 2021;

Publication

Reply to '"Mycobacterium indicus pranii" is a strain of Mycobacterium intracellulare': "M. indicus pranii" is a distinct strain, not derived from M. intracellulare, and is an organism at an evolutionary transition point between...

Rahman S A, Singh Y, Kohli S, et al. mBio. 2015;
Download PDF

Publication

"Mycobacterium indicus pranii" is a strain of Mycobacterium intracellulare.

Alexander D, Turenne C. mBio. 2015; 6 (2) : e00013.
Download PDF

Publication

Molecular analysis of clinical isolates previously diagnosed as Mycobacterium intracellulare reveals incidental findings of "Mycobacterium indicus pranii" genotypes in human lung infection.

Kim S, Park HY, Jeong B, et al. BMC infectious diseases. 2015;
Download PDF

Publication

The combination of a novel immunomodulator with a regulatory T cell suppressing antibody (DTA-1) regress advanced stage B16F10 solid tumor by repolarizing tumor associated macrophages in situ.

Banerjee S, Halder K, Ghosh S, et al. Oncoimmunology. 2015; 4 (3) : e995559.
Download PDF

Publication

Priming with DNA Enhances Considerably the Immunogenicity of hCG β-LTB Vaccine.

Nand KN, Gupta JC, Panda A, et al. American journal of reproductive immunology (New York, N.Y. : 1989). 2015; 74 (4) : 302-8.

Publication

A randomized trial of Mycobacterium w in severe sepsis.

Sehgal IS, Agarwal R, Aggarwal A, et al. Journal of critical care. 2015; 30 (1) : 85-9.

Publication

Immunomodulation in host-protective immune response against murine tuberculosis through regulation of the T regulatory cell function.

Das S, Halder K, Goswami A, et al. Journal of leukocyte biology. 2015; 98 (5) : 827-36.
Download PDF

Publication

Molecular identification of non-tuberculous mycobacteria isolated from clinical specimens in Zambia.

Mwikuma G, Kwenda G, Hang'ombe BM, et al. Annals of clinical microbiology and antimicrobials. 2015;
Download PDF

Publication

Mycobacterium indicus pranii (Mw) inhibits invasion by reducing matrix metalloproteinase (MMP-9) via AKT/ERK-1/2 and PKCα signalling: a potential candidate in melanoma cancer therapy.

Halder K, Banerjee S, Ghosh S, et al. Cancer biology & therapy. 2015;

Publication

Mycobacterium indicus pranii induces dendritic cell activation, survival, and Th1/Th17 polarization potential in a TLR-dependent manner.

Kumar P, John V, Marathe S, et al. Journal of leukocyte biology. 2015; 97 (3) : 511-20.
Download PDF

Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications
  • Organizations

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2023 InfoNTD